Literature DB >> 8789439

An animal model for Norrie disease (ND): gene targeting of the mouse ND gene.

W Berger1, D van de Pol, D Bächner, F Oerlemans, H Winkens, H Hameister, B Wieringa, W Hendriks, H H Ropers.   

Abstract

In order to elucidate the cellular and molecular processes which are involved in Norrie disease (ND), we have used gene targeting technology to generate ND mutant mice. The murine homologue of the ND gene was cloned and shown to encode a polypeptide that shares 94% of the amino acid sequence with its human counterpart. RNA in situ hybridization revealed expression in retina, brain and the olfactory bulb and epithelium of 2 week old mice. Hemizygous mice carrying a replacement mutation in exon 2 of the ND gene developed retrolental structures in the vitreous body and showed an overall disorganization of the retinal ganglion cell layer. The outer plexiform layer disappears occasionally, resulting in a juxtaposed inner and outer nuclear layer. At the same regions, the outer segments of the photoreceptor cell layer are no longer present. These ocular findings are consistent with observations in ND patients and the generated mouse line provides a faithful model for study of early pathogenic events in this severe X-linked recessive neurological disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789439     DOI: 10.1093/hmg/5.1.51

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Ophthalmology in the post-genomic era.

Authors:  G C Black; M E Boulton; P N Bishop; D McLeod
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

Review 2.  Gene disruption in mice: models of development and disease.

Authors:  B S Shastry
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

3.  [Coats disease].

Authors:  B Junker; L L Hansen
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

Review 4.  Mouse b-wave mutants.

Authors:  Machelle T Pardue; Neal S Peachey
Journal:  Doc Ophthalmol       Date:  2014-01-07       Impact factor: 2.379

5.  Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy.

Authors:  James A Poulter; Manir Ali; David F Gilmour; Aine Rice; Hiroyuki Kondo; Kenshi Hayashi; David A Mackey; Lisa S Kearns; Jonathan B Ruddle; Jamie E Craig; Eric A Pierce; Louise M Downey; Moin D Mohamed; Alexander F Markham; Chris F Inglehearn; Carmel Toomes
Journal:  Am J Hum Genet       Date:  2010-02-12       Impact factor: 11.025

6.  Vascular defects and sensorineural deafness in a mouse model of Norrie disease.

Authors:  Heidi L Rehm; Duan-Sun Zhang; M Christian Brown; Barbara Burgess; Chris Halpin; Wolfgang Berger; Cynthia C Morton; David P Corey; Zheng-Yi Chen
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.

Authors:  Amy C Martin; J Derek Thornton; Jiewiu Liu; XiaoFei Wang; Jian Zuo; Monica M Jablonski; Edward Chaum; Frederique Zindy; Stephen X Skapek
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-10       Impact factor: 4.799

Review 8.  Neurodegenerative disorders associated with diabetes mellitus.

Authors:  Michael Ristow
Journal:  J Mol Med (Berl)       Date:  2004-06-03       Impact factor: 4.599

9.  Norrin restores blood-retinal barrier properties after vascular endothelial growth factor-induced permeability.

Authors:  Mónica Díaz-Coránguez; Cheng-Mao Lin; Stefan Liebner; David A Antonetti
Journal:  J Biol Chem       Date:  2020-02-21       Impact factor: 5.157

Review 10.  Taking Stock of Retinal Gene Therapy: Looking Back and Moving Forward.

Authors:  Jean Bennett
Journal:  Mol Ther       Date:  2017-04-05       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.